HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager

The Abstracts Effects of GDP-Reduced Dialysate (Balance^*) for PD on the Epithelial–Mesenchymal Transition (EMT) of the Mesothelial Cell In Vivo and Transcriptome Analysis in Human Peritoneal Mesothelial Cells Exposed to PD Solution Low in Glucose Degradation Products were changed by Multimed Inc. after submission without the authors' approval of such changes. The printed Abstracts, which appeared in Volume 28, Supplement 4, June 2008, pages S12 and S49, both incorrectly identify Balance as a product of Baxter Healthcare BV, Utrecht, Netherlands, when it should have been identified as being manufactured and distributed by Fresenius Medical Care, Bad Homburg, Germany. In addition, the Abstract that appeared on page S49 incorrectly stated that the micro arrays used were supplied by a company named OriGene Technologies. It should have stated that the micro arrays U133 Plus 2.0 GeneChips were provided by Affymetrix.

The publisher acknowledges these errors and the corrected Abstracts are published in this issue of PDI, Volume 28, Number 6.

Copyright © 2008 by Multimed Inc.